Display options
Cite
Shuter J, Yang A, Kim RS, et al. Interest in Tobacco Treatment Delivered During Rideshare Travel. Mayo Clin Proc Innov Qual Outcomes. 2019;3(4):461-465doi: 10.1016/j.mayocpiqo.2019.07.005.
Shuter, J., Yang, A., Kim, R. S., & Brownstein, J. S. (2019). Interest in Tobacco Treatment Delivered During Rideshare Travel. Mayo Clinic proceedings. Innovations, quality & outcomes, 3(4), 461-465. https://doi.org/10.1016/j.mayocpiqo.2019.07.005
Shuter, Jonathan, et al. "Interest in Tobacco Treatment Delivered During Rideshare Travel." Mayo Clinic proceedings. Innovations, quality & outcomes vol. 3,4 (2019): 461-465. doi: https://doi.org/10.1016/j.mayocpiqo.2019.07.005
Shuter J, Yang A, Kim RS, Brownstein JS. Interest in Tobacco Treatment Delivered During Rideshare Travel. Mayo Clin Proc Innov Qual Outcomes. 2019 Oct 22;3(4):461-465. doi: 10.1016/j.mayocpiqo.2019.07.005. eCollection 2019 Dec. PMID: 31993564; PMCID: PMC6978606.
Copy Download .nbib Format: NLM
Share it on

Mayo Clin Proc Innov Qual Outcomes. 2019 Oct 22;3(4):461-465. doi: 10.1016/j.mayocpiqo.2019.07.005. eCollection 2019 Dec.

Interest in Tobacco Treatment Delivered During Rideshare Travel.

Mayo Clinic proceedings. Innovations, quality & outcomes

Jonathan Shuter, Angie Yang, Ryung S Kim, John S Brownstein

Affiliations

  1. Department of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, NY.
  2. Department of Medicine, Albert Einstein College of Medicine, Bronx, NY.
  3. Bronx High School of Science, NY.
  4. Department of Pediatrics, Boston Children's Hospital and Harvard Medical School, Boston, MA.

PMID: 31993564 PMCID: PMC6978606 DOI: 10.1016/j.mayocpiqo.2019.07.005

Abstract

More than 37,000,000 US adults smoke cigarettes. Most are interested in quitting, but rates of successful cessation remain low. Developing more and better approaches to tobacco treatment is a public health priority. The evolution of vehicular travel may present an opportunity for tobacco treatment intervention. We recruited individuals who reported previous use of ridesharing services (eg, Uber or Lyft) at 10 sites in the Boston area. They completed an anonymous survey that collected sociodemographic and tobacco use information and assessed participants' interest in receiving various forms of tobacco treatment during their rideshare rides. Forty-nine adult smokers completed the survey. Mean age = 40.1, 61.2% male, 51.0% white, 16.3% African American/black, 14.3% Latino, and 8.2% Asian. Almost 70% were college graduates, 79.6% worked full time, and 40.8% used ridesharing services ≥ weekly. They smoked a mean of 8.7 cigarettes per day; 35.3% were moderately or highly nicotine dependent, 36.7% also smoked cigars, 34.7% also used e-cigarettes, and 41.7% were in the contemplation or preparation stage of quitting. More than 56% of participants expressed some level of interest in receiving quit-smoking messaging during their rideshare rides. On multivariate analysis, black or Latino race/ethnicity and rideshare frequency of at least once a week were associated with interest in receiving quit-smoking messaging during rideshare rides. The majority of rideshare users who smoke are amenable to the idea of quit-smoking messaging delivered to them during their rides, and interest rates were highest among black or Latino riders and those who used rideshare services most frequently.

© 2019 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc.

Keywords: CI, confidence interval; OR, odds ratio

References

  1. Am J Health Promot. 2011 May-Jun;25(5 Suppl):S11-30 - PubMed
  2. J Med Internet Res. 2014 Jul 16;16(7):e172 - PubMed
  3. N Engl J Med. 2015 Oct 29;373(18):1748-54 - PubMed
  4. Am J Prev Med. 2014 Sep;47(3):242-50 - PubMed
  5. MMWR Morb Mortal Wkly Rep. 2017 Jan 06;65(52):1457-1464 - PubMed
  6. Health Promot Pract. 2019 May;20(3):328-332 - PubMed
  7. Am J Public Health. 2007 Oct;97(10):1878-83 - PubMed
  8. J Clin Psychol Med Settings. 2011 Dec;18(4):392-9 - PubMed
  9. Ann Intern Med. 2015 Nov 17;163(10):806-7 - PubMed
  10. Inj Prev. 2000 Dec;6(4):277-80 - PubMed
  11. Tob Control. 2014 Jan;23(1):14-20 - PubMed

Publication Types

Grant support